@Diego2 - Studie zu EGCG und Lungenfibrose
Hallo Diego,
gerade veröffentlicht:
'Taking oral dietary supplements of epigallocatechin-3-gallate (EGCG) — an antioxidant in green tea — may stop and reverse the pro-fibrotic (scarring) state of the lungs of people with idiopathic pulmonary fibrosis (IPF), a small study suggests.
These early findings support larger studies of EGCG’s anti-fibrotic potential in IPF, which if confirmed, would place EGCG as a therapy candidate for this patient population.'
https://pulmonaryfibrosisnews.com/2020/04/21/green-tea-extract-stops-anti-fibrotic-proc...
Das Produkt
http://www.teavigoinfo.com/teavigo-green-tea.html
wird in Deutschland von der Taiyo GmbH in Schwelm vertrieben.
https://taiyogmbh.com/en/brands/
Unter Umständen interessant.
Gruss,
Sligo